Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Diseases of the Thyroid

  Free Subscription


Articles published in Surgery

Retrieve available abstracts of 82 articles:
HTML format



Single Articles


    September 2025
  1. SATHE SV, Chmiel A, Jones C, Gillanders WE, et al
    Deviating from Thyroid Imaging Reporting and Data Systems (TI-RADS) guidelines in surgical planning for patients with parathyroid disease: What is the clinical impact?
    Surgery. 2025 Sep 30:109705. doi: 10.1016/j.surg.2025.109705.
    PubMed     Abstract available


  2. PLITT G, Mitzukami T, Yehia L, Rabinowitz L, et al
    Targeted RNA sequencing of thyroid tumors from individuals with PTEN hamartoma tumor syndrome reveals a unique transcriptome with a predominantly RAS-like expression profile.
    Surgery. 2025 Sep 29:109697. doi: 10.1016/j.surg.2025.109697.
    PubMed     Abstract available


  3. FUNG MHM, Cheng CC, Luk Y, Lang BHH, et al
    Laryngeal ultrasound-guided adhesive transcutaneous electrodes versus conventional endotracheal electrodes for intraoperative neuromonitoring during thyroid and neck surgery.
    Surgery. 2025 Sep 29:109709. doi: 10.1016/j.surg.2025.109709.
    PubMed     Abstract available


  4. KOWALSKI R, Carlisle K, Park AN, Ricci S, et al
    Patient preferences in papillary thyroid microcarcinoma management are driven by aversion toward complications rather than treatment pathway.
    Surgery. 2025 Sep 25:109694. doi: 10.1016/j.surg.2025.109694.
    PubMed     Abstract available


    August 2025
  5. MICHAELSEN SH, Dossing H, Gerke O, Bjorndal K, et al
    Combined near-infrared autofluorescence and preresection indocyanine green angiography for parathyroid gland preservation during thyroid surgery: A clinical controlled trial.
    Surgery. 2025;187:109623.
    PubMed     Abstract available


  6. GHANI A, Al Darwashi LM, Hajeir MY, Ayesh AR, et al
    Clinical impact of obesity on thyroidectomy outcomes: A systematic review and meta-analysis.
    Surgery. 2025;186:109598.
    PubMed     Abstract available


    July 2025
  7. VAGHAIWALLA TM, Henriksen EM, Chang J, Saghira C, et al
    Reassessing false-negative rate and size cutoff for papillary thyroid cancer with fine-needle aspiration in thyroid nodules.
    Surgery. 2025;186:109577.
    PubMed     Abstract available


    March 2025
  8. VAGHAIWALLA TM, Lew JI
    Letter to the editor regarding: "Impact of chronic lymphocytic thyroiditis on the diagnostic and intraoperative management of papillary thyroid cancer".
    Surgery. 2025 Mar 22:109337. doi: 10.1016/j.surg.2025.109337.
    PubMed    


  9. LOPERA K, Sanabria A
    Threshold-dependent risk of postoperative hypocalcemia in vitamin D-deficient patients undergoing total thyroidectomy: A meta-analysis.
    Surgery. 2025;182:109333.
    PubMed     Abstract available


    February 2025
  10. PAPINI P, Rossi L, Matrone A, De Renzis A, et al
    Prophylactic central neck dissection in clinically node-negative papillary thyroid carcinoma: 10-year impact on surgical and oncologic outcomes.
    Surgery. 2025;181:109258.
    PubMed     Abstract available


  11. AN R, Yun D
    Letter to the editor regarding: "Impact of chronic lymphocytic thyroiditis on the diagnostic and intraoperative management of papillary thyroid cancer".
    Surgery. 2025 Feb 15:109251. doi: 10.1016/j.surg.2025.109251.
    PubMed    


  12. NGO S, Hu TX, Zhu CY, Hughes EG, et al
    Utility of prophylactic central dissection in papillary thyroid carcinoma with clinically apparent lymph node metastases isolated to the lateral neck.
    Surgery. 2025;181:109160.
    PubMed     Abstract available


    January 2025
  13. MORENO LLORENTE P, Alberich Prats M, Garcia Barrasa A, Pascua Sole M, et al
    Postoperative and permanent hypocalcemia after indocyanine green (ICG) angiography-guided total thyroidectomy and central neck dissection: A retrospective cohort study.
    Surgery. 2025;181:109142.
    PubMed     Abstract available


  14. GLOVER A
    Response: Letter to the editor: "Oncogenic mutations in the TP53 and PI-3 kinase/AKT pathway are independent predictors of survival for advanced thyroid cancer: Analysis from the Molecular Screening and Therapeutics (MoST) program".
    Surgery. 2025 Jan 3:109006. doi: 10.1016/j.surg.2024.109006.
    PubMed    


    December 2024
  15. JI X, Liang W, Yu T, Ding C, et al
    Thyroid lobectomy for unilateral TNM T1 and T2 papillary thyroid carcinoma patients with lateral lymph node metastasis.
    Surgery. 2024;180:109028.
    PubMed     Abstract available


  16. PENNESTRI F, Procopio PF, De Crea C, Raffaelli M, et al
    Response letter to the editor: "Is desmoplastic stromal reaction useful to modulate lymph node dissection in sporadic medullary thyroid carcinoma?".
    Surgery. 2024 Dec 19:109001. doi: 10.1016/j.surg.2024.109001.
    PubMed    


  17. VAGHAIWALLA TM, DeTrolio V, Saghira C, Akcin M, et al
    Impact of chronic lymphocytic thyroiditis on the diagnostic and intraoperative management of papillary thyroid cancer.
    Surgery. 2024 Dec 16:108937. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available


  18. MACHENS A, Dralle H
    Letter to the editor: "Is desmoplastic stromal reaction useful to modulate lymph node dissection in sporadic medullary thyroid carcinoma?".
    Surgery. 2024 Dec 6:108960. doi: 10.1016/j.surg.2024.108960.
    PubMed    


  19. WANG W, Wang H, Chen X
    Letter to the editor on "Oncogenic mutations in the TP53 and PI-3 kinase/AKT pathway are independent predictors of survival for advanced thyroid cancer: Analysis from the Molecular Screening and Therapeutics (MoST) program".
    Surgery. 2024 Dec 6:108959. doi: 10.1016/j.surg.2024.108959.
    PubMed    


    November 2024
  20. CHEREAU N, Gaujoux S, Ghander C, Bertocchio JP, et al
    Parathyroid hormone-based algorithm reduces complications after total thyroidectomy.
    Surgery. 2024 Nov 28:108933. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available


  21. PLOTZL A, Wicher A, Jarosz M, Passler C, et al
    A large single-center analysis of postoperative hemorrhage in more than 43,000 thyroid operations: The relevance of intraoperative systolic blood pressure, the individual surgeon, and surgeon-to-patient gender (in-)congruence.
    Surgery. 2024 Nov 15:108910. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available


    October 2024
  22. PRATT CG, Long SA, Whitrock JN, Holm TM, et al
    "Thanks, but no thanks": Factors associated with patients who decline surgical intervention for thyroid cancer.
    Surgery. 2024 Oct 30:S0039-6060(24)00837-7. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available


  23. DICKERSON K, Milas M, Metzger R, Tomeh C, et al
    Neoadjuvant systemic therapy for inoperable differentiated thyroid cancers: Impact on tumor resectability.
    Surgery. 2024 Oct 28:S0039-6060(24)00706-2. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available


  24. CRAIG S, Stretch C, Yeo C, Fan J, et al
    Prognostication with Thyroid GuidePx in the context of tall cell variants.
    Surgery. 2024 Oct 25:S0039-6060(24)00810-9. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available


  25. PROCOPIO PF, Pennestri F, Voloudakis N, La Rocca S, et al
    Is desmoplastic stromal reaction useful to modulate lymph node dissection in sporadic medullary thyroid carcinoma?
    Surgery. 2024 Oct 24:S0039-6060(24)00809-2. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available


  26. FUNG MHM, Luk Y, Lang BHH
    Early second radiofrequency ablation treatment gave rise to significantly greater nodule shrinkage at 12 months than single-session treatment for large-volume benign thyroid nodules.
    Surgery. 2024 Oct 24:S0039-6060(24)00807-9. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available


  27. WILLIAMS JE, Sinha A, Pitt SC, Hughes DT, et al
    It's not that SIMPL-Identifying deficiencies in general surgery trainees' autonomy and competence performing parathyroidectomy and thyroidectomy.
    Surgery. 2024 Oct 18:S0039-6060(24)00780-3. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available


  28. NOVIS E, Glover A, Grady JP, Silvestri A, et al
    Oncogenic mutations in the TP53 and PI-3 kinase/AKT pathway are independent predictors of survival for advanced thyroid cancer: Analysis from the Molecular Screening and Therapeutics (MoST) program.
    Surgery. 2024 Oct 17:S0039-6060(24)00781-5. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available


  29. RAGHUNATHAN R, Jacobs AR, Sant VR, King LJ, et al
    Can large language models address unmet patient information needs and reduce provider burnout in the management of thyroid disease?
    Surgery. 2024 Oct 17:S0039-6060(24)00782-7. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available


  30. CARNABATU CJ, Fetzer DT, Tessnow A, Holt S, et al
    Avoidable biopsies? Validating artificial intelligence-based decision support software in indeterminate thyroid nodules.
    Surgery. 2024 Oct 12:S0039-6060(24)00697-4. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available


  31. ENGELBRECHT-WIGGANS EA, Carlisle K, Yunasan E, Fan C, et al
    Long-term retreatment outcomes after definitive management of Graves' disease with radioactive iodine versus surgery.
    Surgery. 2024 Oct 10:S0039-6060(24)00699-8. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available


  32. TUMATI A, Marshall TE, Greenspun B, Chen Z, et al
    Evaluating the clinical performance of an updated microRNA classifier in indeterminate and RAS-mutated thyroid nodule management: A multi-institutional study.
    Surgery. 2024 Oct 10:S0039-6060(24)00704-9. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available


  33. ZHAO HH, Wilhelm SM
    Exploring ethnic diversity and clinical outcome variabilities in well-differentiated thyroid cancer among the Asian population.
    Surgery. 2024 Oct 8:S0039-6060(24)00698-6. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available


  34. KURTOM S, Liu JB, Doerfler WR, Calcaterra M, et al
    Tumor size and molecular risk group are associated with differentiated thyroid cancer recurrence.
    Surgery. 2024 Oct 8:S0039-6060(24)00710-4. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available


  35. COLLINS RA, McManus C, Kuo EJ, Liou R, et al
    Improvement in thyroid-specific quality of life following radiofrequency ablation of benign thyroid nodules: A USA study.
    Surgery. 2024 Oct 8:S0039-6060(24)00693-7. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available


  36. ARTHURS L, Fredericks S, Attlassy Y, Raghunathan R, et al
    Language-based exclusion associations with racial and ethnic disparities in thyroid cancer clinical trials.
    Surgery. 2024 Oct 7:S0039-6060(24)00696-2. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available


    September 2024
  37. BRAAFLADT S, Allison H, Chung J, Mariash CN, et al
    Dose-dependent relationship between levothyroxine and health-related quality of life in survivors of differentiated thyroid cancer.
    Surgery. 2024 Sep 27:S0039-6060(24)00647-0. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available


  38. OH MY, Park D, Chai YJ, Kim K, et al
    Transoral robotic thyroidectomy: Lessons learned from consecutive series of 1,000 patients.
    Surgery. 2024 Sep 17:S0039-6060(24)00583-X. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available


  39. MELIN SJH, Park SY, Shaker J, Yen TWF, et al
    Evaluation for primary hyperparathyroidism after radioactive iodine treatment in patients with Graves' disease.
    Surgery. 2024 Sep 9:S0039-6060(24)00567-1. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available


    August 2024
  40. MACHENS A, Dralle H
    Response to letter to the editor on "Sporadic noninvasive medullary thyroid neoplasm: A desmoplasia-negative, unifocal, nonmetastatic tumor cured by hemithyroidectomy".
    Surgery. 2024 Aug 30:S0039-6060(24)00222-8. doi: 10.1016/j.surg.2024.
    PubMed    


  41. KIM LT
    Invited commentary on: YMSY-D-23-01181_R2. Overexpression of human DNA polymerase theta (POLQ) is a biomarker of aggressive and DNA repair-deficient papillary thyroid cancers.
    Surgery. 2024 Aug 20:S0039-6060(24)00543-9. doi: 10.1016/j.surg.2024.
    PubMed    


  42. AKGUN E, Uysal M, Avci SN, Berber E, et al
    The use of artificial intelligence to detect parathyroid tissue on ex vivo specimens during thyroidectomy and parathyroidectomy procedures using near-infrared autofluorescence signals.
    Surgery. 2024 Aug 14:S0039-6060(24)00494-X. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available


    July 2024
  43. FEBRERO SANCHEZ B, Iborra E, Sanchez-Pedreno P, Ros-Madrid I, et al
    Analysis of the loss of phosphatase and tensin homolog expression in thyroid tissue for the diagnosis of Cowden syndrome.
    Surgery. 2024 Jul 6:S0039-6060(24)00384-2. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available


    June 2024
  44. FRYE CC, Tennant L, Yeager A, Azimzadeh P, et al
    Overexpression of human DNA polymerase theta is a biomarker of aggressive and DNA repair-deficient papillary thyroid cancers.
    Surgery. 2024 Jun 18:S0039-6060(24)00303-9. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available


  45. LUK Y, Fung MMH, Lui DTW, Liu X, et al
    Long-term kidney outcomes in patients with permanent hypoparathyroidism after total thyroidectomy for benign disease: A population-based study.
    Surgery. 2024 Jun 15:S0039-6060(24)00302-7. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available


    May 2024
  46. BAKLACI M, Eyigor S
    Comments on "Prevalence and risk factors for dysphagia in older adults after thyroid and parathyroid surgery".
    Surgery. 2024 May 31:S0039-6060(24)00184-3. doi: 10.1016/j.surg.2024.
    PubMed    


  47. XIAO X, Zhu Y, Li L, Liao Y, et al
    The effectiveness and safety of thermal ablation for thyroid carcinoma lymph node metastasis are affected by the diameter of metastatic lymph nodes: A meta-analysis.
    Surgery. 2024 May 21:S0039-6060(24)00233-2. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available


  48. MANZELLA A, Kheng M, Chao J, Laird AM, et al
    Association of Medicaid expansion with access to thyroidectomy for benign disease at high-volume centers.
    Surgery. 2024 May 17:S0039-6060(24)00228-9. doi: 10.1016/j.surg.2024.
    PubMed     Abstract available


  49. MASCARENHAS R, Shamshery C, Dhiraj S, Agarwal G, et al
    Letter to the editor on: "Early observations with an ERAS pathway for thyroid and parathyroid surgery: Moving the goalposts forward".
    Surgery. 2024 May 17:S0039-6060(24)00221-6. doi: 10.1016/j.surg.2024.
    PubMed    


  50. CREPEAU PK, Sutton W, Bandeen-Roche K, Walston JD, et al
    Reply to: "Comments on 'Prevalence and risk factors for dysphagia in older adults after thyroid and parathyroid surgery'".
    Surgery. 2024 May 14:S0039-6060(24)00186-7. doi: 10.1016/j.surg.2024.
    PubMed    


    April 2024
  51. PAPAVRAMIDIS T, Chorti A, Cheva A
    Response to "Sporadic noninvasive medullary thyroid neoplasm: A desmoplasia-negative unifocal nonmetastatic tumor cured by hemithyroidectomy".
    Surgery. 2024 Apr 3:S0039-6060(24)00131-4. doi: 10.1016/j.surg.2024.
    PubMed    


    January 2024
  52. HEO DB, Won HR, Tae K, Kang YE, et al
    Clinical impact of coexistent chronic lymphocytic thyroiditis on central lymph node metastasis in low- to intermediate-risk papillary thyroid carcinoma: The MASTER study.
    Surgery. 2024 Jan 27:S0039-6060(23)00967-4. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available


  53. LUND S, Schmitz JJ, Foster T, Dy B, et al
    Ethanol ablation of papillary thyroid carcinoma nodal metastases: Long-term outcomes.
    Surgery. 2024 Jan 8:S0039-6060(23)00908-X. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available


  54. LEE-SAXTON YJ, Palacardo F, Greenberg JA, Egan CE, et al
    Radioactive iodine administration is not associated with improved disease-specific survival in classic papillary thyroid carcinoma greater than 4 cm confined to the thyroid.
    Surgery. 2024;175:215-220.
    PubMed     Abstract available


  55. WRIGHT K, Fisher JC, Rothberger GD, Prescott JD, et al
    Incidental (68)Ga-DOTATATE uptake in thyroid nodules: Is guideline-directed management still appropriate?
    Surgery. 2024;175:228-233.
    PubMed     Abstract available


    December 2023
  56. YAMAMOTO M, Miyauchi A, Ito Y, Fujishima M, et al
    Tumor volume-doubling rate is negatively associated with patient age in papillary thyroid microcarcinomas under active surveillance.
    Surgery. 2023 Dec 22:S0039-6060(23)00887-5. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available


  57. CONROY PC, Wilhelm A, Rajwani T, Mulder M, et al
    Nerve monitoring in endocrine surgery: Practice patterns differ among surgeons for parathyroidectomy and thyroidectomy.
    Surgery. 2023 Dec 21:S0039-6060(23)00889-9. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available


  58. HU QL, Chen L, Kuo EJ, Lee JA, et al
    A national study of postoperative thyroid hormone supplementation rates after thyroid lobectomy.
    Surgery. 2023 Dec 13:S0039-6060(23)00871-1. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available


    November 2023
  59. FINN CB, Sharpe JE, Krumeich LN, Ginzberg SP, et al
    The use and costs of same-day surgery versus overnight admission for total thyroidectomy: A multi-state, all-payer analysis.
    Surgery. 2023 Nov 20:S0039-6060(23)00625-6. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available


  60. CHAO JC, Kheng M, Manzella A, Beninato T, et al
    Malpractice litigation after thyroid surgery: What factors favor surgeons?
    Surgery. 2023 Nov 18:S0039-6060(23)00680-3. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available


  61. MACHADO N, Mortlock R, Maduka R, Souza Cunha AE, et al
    Early observations with an ERAS pathway for thyroid and parathyroid surgery: Moving the goalposts forward.
    Surgery. 2023 Nov 14:S0039-6060(23)00633-5. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available


  62. STURGEON C
    Addressing financial toxicity in thyroid cancer survivors in the United States.
    Surgery. 2023 Nov 10:S0039-6060(23)00755-9. doi: 10.1016/j.surg.2023.
    PubMed    


  63. RUSSELL JO, Desai DD, Noel JE, Hussein M, et al
    Radiofrequency ablation of benign thyroid nodules: A prospective, multi-institutional North American experience.
    Surgery. 2023 Nov 10:S0039-6060(23)00725-0. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available


  64. VISENIO MR, Reddy S, Sturgeon C, Elaraj DM, et al
    Emergency department use after outpatient thyroidectomy across three states.
    Surgery. 2023 Nov 8:S0039-6060(23)00682-7. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available


  65. CREPEAU PK, Sutton W, Sahli Z, Fedorova T, et al
    Prevalence and risk factors for dysphagia in older adults after thyroid and parathyroid surgery.
    Surgery. 2023 Nov 8:S0039-6060(23)00672-4. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available


  66. RAGHUNATHAN R, Longstaff XR, Hughes EG, Li SJ, et al
    Diagnostic performance of molecular testing in indeterminate (Bethesda III and IV) thyroid nodules with Hurthle cell cytology.
    Surgery. 2023 Nov 3:S0039-6060(23)00634-7. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available


  67. LIN AC, Liu Z, Lee J, Ranvier GF, et al
    Generating a multimodal artificial intelligence model to differentiate benign and malignant follicular neoplasms of the thyroid: A proof-of-concept study.
    Surgery. 2023 Nov 2:S0039-6060(23)00635-9. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available


    October 2023
  68. GIMBLET GR, Whitt J, Houson HA, Lin D, et al
    Thyroid-stimulating hormone receptor (TSHR) as a target for imaging differentiated thyroid cancer.
    Surgery. 2023 Oct 31:S0039-6060(23)00631-1. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available


  69. TUMATI A, Egan CE, Lee-Saxton YJ, Marshall TE, et al
    Clinical utility of a microRNA classifier in cytologically indeterminate thyroid nodules with RAS mutations: A multi-institutional study.
    Surgery. 2023 Oct 29:S0039-6060(23)00626-8. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available


  70. CARLISLE KM, Brown JP, Kim J, Turner DJ, et al
    Age-stratified comparison of active surveillance versus radiofrequency ablation for papillary thyroid microcarcinoma using decision analysis.
    Surgery. 2023 Oct 21:S0039-6060(23)00638-4. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available


  71. COLLINS RA, McManus C, Kuo EJ, Liou R, et al
    The impact of social determinants of health on thyroid cancer mortality and time to treatment.
    Surgery. 2023 Oct 21:S0039-6060(23)00627-X. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available


  72. ROMERO-VELEZ G, Avci SN, Isiktas G, Ergun O, et al
    Comparison of incidental parathyroid tissue detection rates on pathology after total thyroidectomy performed with or without near-infrared autofluorescence imaging.
    Surgery. 2023 Oct 20:S0039-6060(23)00639-6. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available


  73. HUSSEIN M, Toraih E, Issa PP, Omar M, et al
    From ablation to operation: Unraveling the surgical outcomes and complications of thyroidectomy after radiofrequency ablation.
    Surgery. 2023 Oct 20:S0039-6060(23)00629-3. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available


  74. ZHAO HH, Wilhelm SM
    Pediatric thyroid cancer: Socioeconomic disparities and their impact on access to care.
    Surgery. 2023 Oct 18:S0039-6060(23)00600-1. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available


  75. DRALLE H, Brandenburg T, Weber F, Fuhrer-Sakel D, et al
    Sporadic noninvasive medullary thyroid neoplasm: A desmoplasia-negative unifocal nonmetastatic tumor cured by hemithyroidectomy.
    Surgery. 2023 Oct 9:S0039-6060(23)00589-5. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available


    September 2023
  76. ROMERO-VELEZ G, Noureldine SI, Burneikis T, Siperstein A, et al
    High-volume endocrine surgeons perform thyroid surgery at decreased cost despite increased case relative value units.
    Surgery. 2023 Sep 26:S0039-6060(23)00506-8. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available


  77. AKGUN E, Romero-Velez G, Berber E
    Assessing the efficacy of thyroid nodule radiofrequency ablation using patient-reported outcome measures.
    Surgery. 2023 Sep 21:S0039-6060(23)00514-7. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available


    August 2023
  78. MONTGOMERY KB, Fazendin JM, Broman KK
    Evolving variation in the extent of surgery for low-risk papillary thyroid cancer in the United States.
    Surgery. 2023 Aug 5:S0039-6060(23)00428-2. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available


    June 2023
  79. STEVENS A, Meier J, Bhat A, Knight SJ, et al
    Reassessing surgical guidelines for papillary thyroid cancer impact on survival: Expanding indications for lobectomy.
    Surgery. 2023 Jun 29:S0039-6060(23)00328-8. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available


    May 2023
  80. KUO TC, Chen KY, Lai CW, Wang YC, et al
    Synergic evacuation device helps smoke control during endoscopic thyroid surgery.
    Surgery. 2023 May 16:S0039-6060(23)00187-3. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available


    April 2023
  81. SAKOWITZ S, Bakhtiyar SS, Khoraminejad B, Ebrahimian S, et al
    Thyroid surgery outcomes in octogenarians: A national analysis.
    Surgery. 2023 Apr 11:S0039-6060(23)00053-3. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available


    March 2023
  82. KANG YJ, Stybayeva G, Hwang SH
    Surgical completeness and safety of minimally invasive thyroidectomy in patients with thyroid cancer: A network meta-analysis.
    Surgery. 2023 Mar 25:S0039-6060(23)00110-1. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diseases of the Thyroid is free of charge.